Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04582045 · ClinicalTrials.gov registry record
Effect of Prophylactic Negative Pressure Versus Silver Impregnated Silicone Bandage on C-Section Infection Rates
A clinical trial, sponsored by HealthPartners Institute.
- Completed
- Registry status
- 1,064
- Enrollment target
NCT04582045: Completed study, sponsored by HealthPartners Institute.
NCT04582045 is a clinical trial that has completed, run by HealthPartners Institute. The registered enrollment target is 1,064 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04582045 has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- 1,064 participants
- Enrollment target
Study Summary
Effect of Prophylactic Negative Pressure versus Silver Impregnated Silicone Bandage on Cesarean Section Surgical Site Infection Rate
Primary Outcome
rate of post operative infection
Interventions
- DEVICE silver impregnated dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,064 participants |
| Start Date | 2019-03-01 |
| Est. Completion | 2021-06-15 |
What the finished NCT04582045 record still lists
NCT04582045 is an observational study that tracks outcomes without assigning an intervention. Its 1,064 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which silver impregnated dressing is the first listed.
NCT04582045 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04582045 about?
NCT04582045 is a clinical study titled "Effect of Prophylactic Negative Pressure Versus Silver Impregnated Silicone Bandage on C-Section Infection Rates". Effect of Prophylactic Negative Pressure versus Silver Impregnated Silicone Bandage on Cesarean Section Surgical Site Infection Rate
What is the current status of trial NCT04582045?
This trial is currently completed. The enrollment target is 1,064 participants. The study started on 2019-03-01. Estimated completion is 2021-06-15.
What interventions are being tested in trial NCT04582045?
The interventions under investigation include: silver impregnated dressing (DEVICE).
Who is sponsoring clinical trial NCT04582045?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04165798 · 1,065 participants
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
- NCT05520762 · 1,060 participants · NA
Hospital Airway Resuscitation Trial
- NCT05911568 · 1,060 participants
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
- NCT07140172 · 1,060 participants · NA
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI